What Tempest Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 0 |
| Total trades | 0 | 2 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 1,388,892 |
| Disposed | 0 | 0 |
| Net activity | +0 | +1,388,892 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Angel Matthew | CEO and President | Mar 24 | Open-market buy · P | +231,482 | $2.16 | +$500K | 231,482 |
| Angel Matthew | CEO and President | Mar 24 | Open-market buy · P | +231,482 | $2.16 | +$500K | 231,482 |
| Versant Venture Capital VI, L.p. | 10% owner | Aug 12 | Open-market sale · S | −387,999 | $1.10 | −$427K | 209,941 |
| Versant Venture Capital VI, L.p. | 10% owner | Aug 08 | Open-market sale · S | −400,000 | $1.35 | −$540K | 597,940 |
| Brady Stephen R | President and CEO | Jul 03 | Open-market buy · P | +35,000 | $2.11 | +$73.9K | 46,376 |
| Whiting Samuel | Chief Medical Officer | Jul 02 | Open-market buy · P | +4,672 | $2.13 | +$9.95K | 9,573 |
| Trojanowski Justin | Corporate Controller | Jun 28 | Open-market buy · P | +7,500 | $2.16 | +$16.2K | 22,168 |
| Woiwode Thomas | Director | Apr 29 | Open-market buy · P | +2,118,644 | $2.36 | +$5M | 2,118,644 |
| Dubensky Thomas W. | President | Jan 07 | Open-market buy · P | +2,000 | $4.78 | +$9.56K | 113,343 |
| Whiting Samuel | Chief Medical Officer | Jan 06 | Open-market buy · P | +1,700 | $4.80 | +$8.17K | 1,901 |
| Woiwode Thomas | Director | Jun 25 | Grant / award · A | +7,377 | — | — | 7,377 |
| Woiwode Thomas | Director | Jun 25 | Grant / award · A | +1,171,094 | — | — | 1,171,094 |
| Woiwode Thomas | Director | Jun 25 | Grant / award · A | +997,940 | — | — | 997,940 |
| Xu Stella | Director | Jun 25 | Grant / award · A | +579,710 | — | — | 579,710 |
| Whiting Samuel | Chief Medical Officer | Jun 25 | Grant / award · A | +201 | — | — | 201 |
| Dubensky Thomas W. | President | Jun 25 | Grant / award · A | +111,343 | — | — | 111,343 |
| Lorenzo Pierre | Corporate Controller | Jun 25 | Grant / award · A | +53 | — | — | 53 |
| Gallagher Carol Giltner | Director | Dec 07 | Grant / award · A | +23,684 | — | — | 23,684 |
| Gallagher Carol Giltner | Director | Dec 07 | Grant / award · A | +8,249 | — | — | 8,249 |
| Kozin Marc D | Director | Dec 07 | Grant / award · A | +831 | — | — | 7,740 |
Loading...
